P-glycoprotein, considered an ATP-dependent drug efflux pump for xenobiotic compounds, has been extremely expressed on the surface of the endothelial cells contributing to the reduction in chemotherapeutic drug infiltration to particular places, particularly in the case of cerebral malignancies therapy where anti-cancer drugs have been commonly unable of passing through the BBB. The gene discussed is ABCB1; the disease is cancer.